Silicon isn't just for computers. It can make a pretty good kidney, too.

For nearly two decades, UCSF Bioengineering professor Shuvo Roy, PhDWilliam Fissell, MD, and David Humes, MD, have been developing an implantable bioartificial kidney as an alternative treatment for end-stage renal disease. Under the guidance of FDA and a new expedited regulatory plan, the team has completed two years of preclinical testing and plans to move into humans in early 2018 and gain regulatory approval by 2020. 

Continue reading

Stacy Kim